The acetylcholinesterase inhibitor rivastigmine does not alter total choices for methamphetamine, but may reduce positive subjective effects, in a laboratory model of intravenous self-administration in human volunteers - De La Garza, R; Mahoney, J J, 3rd; Culbertson, C (Pharmacol Biochem Behav, 2008)
et al.